설명
Pathway enrichment analysis reveals metabolic pathways significantly disrupted in intestinal fibrosis, including bile acid metabolism and short-chain fatty acid production.
Figure 6
ChartSource Paper
Multiomics reveals microbial metabolites as key actors in intestinal fibrosis in Crohn's disease.Cite This Figure
![Figure 6: Pathway enrichment analysis reveals metabolic pathways significantly disrupted in intestinal fibrosis, including bile acid metabolism and short-chain fatty acid production.]() > Source: Xuehua Li et al. "Multiomics reveals microbial metabolites as key actors in intestinal fibrosis in." *EMBO molecular medicine*, 2024. PMID: [39271960](https://pubmed.ncbi.nlm.nih.gov/39271960/)
<figure> <img src="" alt="Pathway enrichment analysis reveals metabolic pathways significantly disrupted in intestinal fibrosis, including bile acid metabolism and short-chain fatty acid production." /> <figcaption>Figure 6. Pathway enrichment analysis reveals metabolic pathways significantly disrupted in intestinal fibrosis, including bile acid metabolism and short-chain fatty acid production.<br> Source: Xuehua Li et al. "Multiomics reveals microbial metabolites as key actors in intestinal fibrosis in." <em>EMBO molecular medicine</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39271960/">39271960</a></figcaption> </figure>